Skip to main content
JAMA - Update/Review of Hemochromatosis Dx and Rx.
- 5 gene defects in hepcidin. 95% HFE & the C282Y variant
- 9

Dr. John Cush RheumNow

3 years 10 months ago
JAMA - Update/Review of Hemochromatosis Dx and Rx. - 5 gene defects in hepcidin. 95% HFE & the C282Y variant - 90% are asymptomatic - Suspicion w/ arthralgias, LFTs, hepatomegaly, cardiomyopathy, 1st degr relative - Untreated, 9% risk of cirrhosis https://t.co/LWbIbLITK9 https://t.co/xDpA16K0tm
A nemesis is so much more than the "enemy". Your nemesis defines what matters most to you and how you will overcome. Seth Godin once said, “Pick your enemies, pick your future”.
A study in the Annals of Internal Medicine reports chronic kidney disease (CKD) patients can be safely treated with allopurinol without an increased risk of mortality.
Hyaluronic Acid Knee Injections Equivalent to Placebo

In the United States, where over $300 million is spent annually o

Dr. John Cush RheumNow

3 years 10 months ago
Hyaluronic Acid Knee Injections Equivalent to Placebo In the United States, where over $300 million is spent annually on intraarticular hyaluronic acid injections, yet another study shows such therapy to be no better than placebo. https://t.co/bBEwpId84L https://t.co/5msGqViTpz
Drug-Induced Lupus from Proton Pump Inhibitors

A wide range of therapies have been implicated in causing drug-induced l

Dr. John Cush RheumNow

3 years 10 months ago
Drug-Induced Lupus from Proton Pump Inhibitors A wide range of therapies have been implicated in causing drug-induced lupus erythematosus (DIL); now it appears that proton pump inhibitors (PPIs) can be added to the list of causative drugs. https://t.co/Jp3oNUhP6c https://t.co/AcC4mM0nLM
Effect of Intraarticular Steroid Shots on Knee OA Outcomes

In patients with osteoarthritis of the knee, intra-articular

Dr. John Cush RheumNow

3 years 10 months ago
Effect of Intraarticular Steroid Shots on Knee OA Outcomes In patients with osteoarthritis of the knee, intra-articular injections of steroids did not increase rates of either disease progression or subsequent knee replacement surgery, researchers said. https://t.co/yqVHPmqzzi https://t.co/k8dMADHg7P
Hydroxychloroquine Update from ACR22
JAMA - Update/Review of Hemochromatosis Dx and Rx.
- 5 gene defects in hepcidin. 95% HFE & the C282Y variant
- 9

Dr. John Cush RheumNow

3 years 10 months ago
JAMA - Update/Review of Hemochromatosis Dx and Rx. - 5 gene defects in hepcidin. 95% HFE & the C282Y variant - 90%are asymptomatic - Suspicion w/ arthralgias, LFTs, hepatomegaly, cardiomyopathy, 1st degr relative - Untreated, 9% risk of cirrhosis https://t.co/xFTMqkOMSE https://t.co/CmiokvIGvD
A colleague of mine once told me an interesting story of how her father, who was a doctor, misdiagnosed his wife with fibromyalgia when she actually had psoriatic arthritis with enthesitis all along. I would venture out and say that the average physician would have trouble evaluating enthesitis because even we, as rheumatologists do! 
Impressive data on novel treatment for SLE were presented at the EULAR22 Congress. A disease that is difficult to study due to its pleomorphic presentation, unpredictable disease course, and high mortality rates, SLE is considered the dragon of all autoimmune diseases. Here are highlights of four exciting abstracts presented at the meeting with emerging therapeutics designed to slay the beast. 
RT @gurdeep_dulay: #POTS

Postural orthostatic tachycardia syndrome - how it might link to other conditions

https://t

Dr Gurdeep Dulay gurdeep_dulay

3 years 10 months ago
#POTS Postural orthostatic tachycardia syndrome - how it might link to other conditions https://t.co/Ekn6KtOrC4 #Fibromyalgia #chronicillness #migraine #hypermobility #EDS https://t.co/JX1WDm2KKn
RT @DrScottLear: $520 billion is the estimated cost of physical inactivity from 2020 to 2030 @LancetGH: https://t.co/Jyn

Scott Lear, PhD DrScottLear

3 years 10 months ago
$520 billion is the estimated cost of physical inactivity from 2020 to 2030 @LancetGH: https://t.co/JynmtU9oCF Of the expected 500 million preventable cases of disease, 43% due to #depression and #anxiety. #MentalHealthMatters @fiona_bull https://t.co/sVjkceNGiq
No Special Heart Risk With JAK Inhibitors, Study Finds

Patients taking JAK inhibitors for RA experienced similar cardio

Dr. John Cush RheumNow

3 years 10 months ago
No Special Heart Risk With JAK Inhibitors, Study Finds Patients taking JAK inhibitors for RA experienced similar cardiovascular outcomes as those using the TNF blocker adalimumab (Humira), analysis of French national registry data indicated. https://t.co/i0oUoTSmqF https://t.co/qrJMQbpqus
×